A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...

Cambrex is investing $120 million to expand US API manufacturing, enhancing supply chain security and resilience. The Charles City, IA site will see a 40% capacity increase, supporting reshoring of ...

ROCKINGHAM COUNTY, Va. (WDBJ) - Pharmaceutical company Merck will make a $3 billion investment into building a manufacturing facility that’ll bring jobs to Rockingham County, according to Governor ...

EXCLUSIVE — Merck will be making a $70 billion investment in U.S.-based research and manufacturing starting in 2025, the pharmaceutical company announced on Monday. The company officially kicked off ...

Merck & Co. will build a $3 billion pharmaceutical manufacturing facility in Elkton that is expected to create 500 jobs, Gov. Glenn Youngkin and the company announced at a ceremonial groundbreaking ...

New state-of-the-art active pharmaceutical ingredient (API) facility will manufacture immunology, oncology and neuroscience medicines Facility expected to be fully operational and serving patients by ...

In May 2025, the Trump administration issued an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines” directing the Food and Drug Administration (FDA) and the ...

President Trump’s new pharmaceutical tariff policy throws another wrench into an already increasingly complex drug supply chain, with experts calling for more clarity and details into the White ...

President Donald Trump says 100% tariffs on certain pharmaceuticals will take effect next week, but there are several exemptions. President Donald Trump says a 100% tariff on some foreign-made ...

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-dependent ...